- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 2863686-81-9] DRB18
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-145963 |
| Brand: | MCE |
| CAS: | 2863686-81-9 |
Overview
| MDL | - |
|---|---|
| Molecular Weight | 382.88 |
| Molecular Formula | C22H23ClN2O2 |
| SMILES | ClC1=CC(NCC2=CC(O)=C(C)C=C2)=C(NCC3=CC=C(C)C(O)=C3)C=C1 |
Summary
DRB18 is a potent pan-class GLUT inhibitor. DRB18 alters energy-related metabolism in A549 cells by changing the abundance of metabolites in glucose-related pathways. DRB18 can eventually lead to G1/S phase arrest and increase oxidative stress and necrotic cell death. DRB18 has anti-tumor activity [1] .
IC50 & Target
GLUT [1]
In Vitro
DRB18 (0-10 μM; 30 min) reduces glucose uptake in GLUT1-4-expressed HEK293 cell lines in a dose-dependent manner with IC
50
s varying from ~ 900 nM to ~ 9 μM
[1]
.
DRB18 (5 and 10 μM; 72 hours) causes cell cycle arrest in the G1/S phase transition
[1]
.
DRB18 (5 and 10 μM; 72 hours) increases ROS levels in A549 cells
[1]
.
DRB18 (5 and 10 μM; 72 hours) reduces expression of glycosylated GLUT1 and GLUT2-4 in A549 cells in a dose-dependent manner
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay
| Cell Line: | GLUT1-4-expressed HEK293 cell lines [1] |
| Concentration: | 0-10 μM |
| Incubation Time: | 30 min |
| Result: | Reduced glucose uptake in these cell lines in a dose-dependent manner with IC 50 s varying from ~ 900 nM to ~ 9 μM. |
Cell Cycle Analysis
| Cell Line: | A549 [1] |
| Concentration: | 5 and 10 μM |
| Incubation Time: | 72 hours |
| Result: | Caused cell cycle arrest in the G1/S phase transition. |
Western Blot Analysis
| Cell Line: | A549 [1] |
| Concentration: | 5 and 10 μM |
| Incubation Time: | 72 hours |
| Result: | Reduced expression of glycosylated GLUT1 and GLUT2-4 in A549 cells in a dose-dependent manner. |
Western Blot Analysis
| Cell Line: | A549 [1] |
| Concentration: | 5 and 10 μM |
| Incubation Time: | 72 hours |
| Result: | Reduced expression of glycosylated GLUT1 and GLUT2-4 in A549 cells in a dose-dependent manner. |
In Vivo
DRB18 (10 mg/kg; IP; thrice a week for 5 weeks) inhibits tumors volume by 44% and tumors weight by 43% [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: | Male NU/J nude mice (3-4 weeks; tumor cell-injected) [1] |
| Dosage: | 10 mg/kg |
| Administration: | IP; thrice a week for 5 weeks |
| Result: | The tumors were 44% smaller by volume and 43% smaller by weight, also showed DRB18 decreased expression of GLUT1-4 (Fig. 5f) and reduced proliferative capacity within the xenografted tumor. |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : 50 mg/mL ( 130.59 mM ; ultrasonic and warming and heat to 60°C)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.6118 mL | 13.0589 mL | 26.1178 mL |
| 5 mM | 0.5224 mL | 2.6118 mL | 5.2236 mL |
| 10 mM | 0.2612 mL | 1.3059 mL | 2.6118 mL |
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.